Address
Asset Management Co Venture Capital
2100 Geng Road
Suite 200
Palo Alto, CA 94303
United States
Phone
Website
Recent investment activity
KANDO id: 3817
Corporate information
Founders
Also known as
Asset Management Ventures
AMV
Registration country
Company type
Early-stage venture capital firm investing in digital health.Funding rounds
Investment preferences
Minimum investment (USD)
200,000
Maximum initial investment (USD)
2,000,000
Investment size comment
USD 1 million sweet spot.
Stage focus
Investment activity status
Active investor
Selected investments
Displaying 51 - 75 of 83| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Teradyne Inc | N/A | ||||
|
|
Trivascular Inc | A medical device company that has developed endovascular repair devices to treat abdominal aortic aneurysms. | N/A | |||
|
|
Verity Inc | N/A | ||||
|
|
VetCentric Inc | N/A | ||||
|
|
ViaCyte Inc | N/A | ||||
|
|
Virtio Corp | N/A | ||||
|
Amgen Inc | N/A | ||||
|
Apollo Computer Inc | Workstation class computers and instruments company. | N/A | |||
|
Applied Micro Circuits Corp | N/A | ||||
|
|
Biogen Idec Inc | N/A | ||||
|
|
Biomimedica Inc | N/A | ||||
|
|
BiPar Sciences Inc | Biopharmaceutical company developing and commercializing tumor-selective drugs for cancer patients. | Series C | |||
|
|
BiPar Sciences Inc | Biopharmaceutical company developing and commercializing tumor-selective drugs for cancer patients. | Series B | |||
|
|
BiPar Sciences Inc | Biopharmaceutical company developing and commercializing tumor-selective drugs for cancer patients. | Series A | |||
|
CardioDx Inc | Series F Initial investment | ||||
|
|
CardioDx Inc | Series E Initial investment | ||||
|
|
CardioDx Inc | Series D Initial investment | ||||
|
|
Coapt Systems Inc | Coapt Systems develops, manufactures and markets a range of bio-absorbable implants for use in soft tissue fixation. | Debt | |||
|
|
Coapt Systems Inc | Coapt Systems develops, manufactures and markets a range of bio-absorbable implants for use in soft tissue fixation. | Series E | |||
|
|
Coapt Systems Inc | Coapt Systems develops, manufactures and markets a range of bio-absorbable implants for use in soft tissue fixation. | Series D | |||
|
|
Coapt Systems Inc | Coapt Systems develops, manufactures and markets a range of bio-absorbable implants for use in soft tissue fixation. | Series C | |||
|
Freenome Inc | Liquid biopsy diagnosis platform. | Series A Initial investment | |||
|
HealthTap Inc | N/A | ||||
|
|
InteKrin Therapeutics Inc | Biopharmaceutical company focused on developing and commercializing breakthrough therapeutics for neuroendocrine, metabolic, and immune disorders.. | Series C | |||
|
|
Loomia Inc | Social recommendations solutions for online content businesses | Series A |